biopharmaceutical company
Issues related to pharmaceutical IP and supply chain. Implementation of Tax Cuts and Jobs Act (P.L.115-97). Biopharmaceutical innovation and patent policy issues.
Trademark legislative proposals.
Bayh-Dole march-in rights policy issues. Issues related to health care, the Food and Drug Administration (FDA), oncology coverage, 340B Program, drug pricing, importation of biopharmaceuticals, international pharmaceutical supply chain, and education around COVID-19 therapies.
Executive Order on Access to Affordable Life-saving Medications (E.O.13937); Executive Order on Increasing Drug Importation to Lower Prices for American Patients (E.O.13938); Executive Order on Lowering Prices for Patients by Eliminating Kickbacks to Middlemen (E.O.13939); Executive Orders on Lowering Drug Prices by Putting America First (E.O.13947, E.O.13948); Executive Order on Combating Public Health Emergencies and Strengthening National Security by Ensuring Essential Medicines, Medical Countermeasures, and Critical Inputs Are Made in the United States (E.O.13944); Executive Order on An America-First Healthcare Plan (E.O.13951).
S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act. FY2022 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act; H.R.748, CARES Act (P.L.116-136) implementation; H.R.133, Consolidated Appropriations Act, 2021 (P.L.116-260) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); all bio-pharmaceutical related provisions. General issues related to Medicare and Medicaid, including: Part D Medicare Program; Medicare Part B reimbursement; Proposed Part B IPI Demonstration Project; Drug Pricing; Medicaid rebates and AMP Cap;      
H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2); H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes.
TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code CPT - Copyright/Patent/Trademark HCR - Health Issues BUD - Budget/Appropriations MMM - Medicare/Medicaid
11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 11 - Executive Office of the President (EOP) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN MATHEW LAPINSKI HUNTER MOORHEAD JASON BENJAMIN VAN PELT SHAY MICHAEL HANCOCK JASON GLEASON CHRIS J MILLER SALIM ALAMEDDIN